NDC 70518-2906

emtricitabine

Emtricitabine

emtricitabine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Emtricitabine.

Product ID70518-2906_b20abe69-cb5e-3d55-e053-2995a90a7501
NDC70518-2906
Product TypeHuman Prescription Drug
Proprietary Nameemtricitabine
Generic NameEmtricitabine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2020-10-12
Marketing CategoryANDA / ANDA
Application NumberANDA091168
Labeler NameREMEDYREPACK INC.
Substance NameEMTRICITABINE
Active Ingredient Strength200 mg/1
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 70518-2906-0

4 CAPSULE in 1 BLISTER PACK (70518-2906-0)
Marketing Start Date2020-10-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "emtricitabine" or generic name "Emtricitabine"

NDCBrand NameGeneric Name
69097-642emtricitabineemtricitabine
70518-2906emtricitabineemtricitabine
46014-0601Emtrivaemtricitabine
53808-0801Emtrivaemtricitabine
61958-0601EmtrivaEMTRICITABINE
61958-0602EmtrivaEMTRICITABINE
70518-1847EmtrivaEMTRICITABINE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.